Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Current understanding of cardiorenal syndrome in children
https://doi.org/10.21508/1027-4065-2026-71-2-18-24
Abstract
Cardiorenal syndrome is a disorder of the heart and kidneys, in which acute or chronic damage to one of these organs can cause acute or chronic damage to the other organ. Despite existing research, the problem of cardiorenal syndrome remains insufficently studied. Cardiorenal syndrome in children has unique pathogenetic mechanisms and clinical manifestations that require special attention. There is also a lack of standardized diagnostic approaches in children. The article presents various approaches to classification, the evolution of the concept of cardiorenal relationships, and the current understanding of the pathogenesis of cardiorenal syndrome.
About the Authors
A. P. Pakhomov
Orenburg State Medical University
Russian Federation
Russian Federation
460014, Orenburg
I. V. Zorin
Orenburg State Medical University
Russian Federation
Russian Federation
460014, Orenburg
References
1. Ronco C., House A.A., Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med. 2008; 34(5): 957–62. DOI: 10.1007/s00134-008-1017-8
2. Kobalava Zh.D., Villewalde S.V., Efremovtseva M.A., Moiseev V.S. Cardio-renal interrelation: modern view. Kardiovaskulyarnaya terapiya i profilaktika. 2010; 9(4): 4–11. (in Russ.).
3. Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R., Cardiorenal syndrome, J. Am. Coll. Cardiol. 2008; 52(19): 1527–1539. DOI: 10.1016/j.jacc.2008.07.051
4. Reznik E.V., Nikitin I.G. Сardiorenal syndrome in patients with chronic heart failure as a stage of the cardiorenal continuum (part I): definition, classification, pathogenesis, diagnosis, epidemiology. Arhiv” vnutrennej mediciny. 2019; 9(1): 5–22 / (in Russ.). DOI: 10.20514/2226-6704-2019-9-1-5-22
5. Kula A.J., Bartlett D. Cardiorenal syndrome: evolving concepts and pediatric knowledge gaps. Pediatr Nephrol. 2025; 40(3): 651–660. DOI: 10.1007/s00467-024-06517-z
6. Ceravolo G., Macchia T., Cuppari C., Dipasquale V., Gambadauro A., Casto C. et al. Update on the Classification and Pathophysiological Mechanisms of Pediatric Cardiorenal Syndromes. Children (Basel). 2021; 8(7): 528. DOI: 10.3390/children8070528
7. Erman M.V., Pervunina T.M., Moiseeva O.M. Pediatric cardiorenal syndrome epidemiology. Nefrologiya. 2012;16(4):62–68 (in Russ.). DOI: 10.24884/1561-6274-2012-16-4-62-68
8. Zannad F., Rossignol P. Cardiorenal Syndrome Revisited. Circulation. 2018; 138(9): 929–944. DOI: 10.1161/CIRCULATIONAHA.117.028814
9. Zhang Y., Jiang Y., Yang W., Shen L., He B. Chronic Secondary Cardiorenal Syndrome: The Sixth Innovative Subtype. Front Cardiovasc Med. 2021; 8: 639959. DOI: 10.3389/fcvm.2021.639959
10. Kazory A., Ronco C. Advances in Cardiorenal Medicine: The Year 2023 in Review. Cardiorenal Med. 2024; 14(1): 123–128. DOI: 10.1159/000537785
11. Arabidze G.G., Mamedov M.N. Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue. Russian Journal of Cardiology. 2024;29(5):5772. (in Russ.). DOI: 10.15829/1560-4071-2024-5772
12. Abreu A.P., Drager L.F., Almeida M.Q., Bortolotto L.A., Lopes H.F. Cardiovascular-kidney-metabolic Syndrome: a current and urgent concept. J Bras Nefrol. 2025; 47(2): e20240277. DOI: 10.1590/2175-8239-JBN-2024-0277en
13. Ndumele C.E., Rangaswami J., Chow S.L., Neeland I.J., Tuttle K.R., Khan S.S. et al. American Heart Association. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023; 148(20): 1606–1635. DOI: 10.1161/CIR.0000000000001184
14. Rowntree LG, Fitz R, Geraghty JT. The effects of experimental chronic passive congestion on renal function. Arch Intern Med (Chic). 1913; XI(2): 121–147. DOI:10.1001/archinte.1913.00060260002001
15. Xu X., Zhang B., Wang Y., Shi S., Lv J., Fu Z. et al. Renal fibrosis in type 2 cardiorenal syndrome: An update on mechanisms and therapeutic opportunities. Biomed Pharmacother. 2023; 164: 114901. DOI: 10.1016/j.biopha.2023.114901
16. Basile D.P. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007; 72(2): 151–6. DOI: 10.1038/sj.ki.5002312
17. Virzì G.M., Clementi A., Battaglia G.G., Ronco C. MultiOmics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes. Cardiorenal Med. 2019; 9(4): 201–211. DOI: 10.1159/000497748
18. Virzì G.M., Zhang J., Nalesso F., Ronco C., McCullough P.A. The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome. Cardiorenal Med. 2018; 8(2): 92–104. DOI: 10.1159/000485937
19. Zhang J., Bottiglieri T., McCullough P.A. The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome. Cardiorenal Med. 2017; 7(2): 104–117. DOI: 10.1159/000452283
20. Liberale L., Badimon L., Montecucco F., Lüscher T.F., Libby P., Camici G.G. Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2022; 79(8): 837–847. DOI: 10.1016/j.jacc.2021.12.017
21. Akhter M.S., Goodwin J.E. Endothelial Dysfunction in Cardiorenal Conditions: Implications of Endothelial Glucocorticoid Receptor-Wnt Signaling. Int J Mol Sci. 2023; 24(18): 14261. DOI: 10.3390/ijms241814261
22. Guyton A.C. The surprising kidney-fluid mechanism for pressure control--its infinite gain! Hypertension. 1990; 16(6): 725–30. DOI: 10.1161/01.hyp.16.6.725
23. Matsuura R., Yamashita T., Hayase N., Hamasaki Y., Noiri E., Numata G. et al. Preexisting heart failure with reduced ejection fraction attenuates renal fibrosis after ischemia reperfusion via sympathetic activation. Sci Rep. 2021; 11(1): 15091. DOI: 10.1038/s41598-021-94617-3
24. Zakeri R., Sangaralingham S.J., Sandberg S.M., Heublein D.M., Scott C.G., Burnett J.C. Jr. Urinary C-type natriuretic peptide: a new heart failure biomarker. JACC Heart Fail. 2013; 1(2): 170–7. DOI: 10.1016/j.jchf.2012.12.003
25. Ljungman S., Laragh J.H., Cody R.J. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs. 1990; 39 (4): 10–21. DOI: 10.2165/00003495-199000394-00004
26. Ichikawa I., Pfeffer J.M., Pfeffer M.A., Hostetter T.H., Brenner B.M. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res. 1984; 55(5): 669–75. DOI: 10.1161/01.res.55.5.669
27. Rea M.E., Dunlap M.E. Renal hemodynamics in heart failure: implications for treatment. Curr Opin Nephrol Hypertens. 2008; 17(1): 87–92. DOI: 10.1097/MNH.0b013e3282f357da
28. Ratnasamy C., Kinnamon D.D., Lipshultz S.E., Rusconi P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J. 2008; 155(3): 527–33. DOI: 10.1016/j.ahj.2007.11.001
29. Blake WD, Wegria R et al. Effect of increased renal venous pressure on renal function. Am J Physiol. 1949 Apr;157(1):1–13. DOI: 10.1152/ajplegacy.1949.157.1.1. PMID: 18130215
30. Verbrugge F.H., Dupont M., Steels P., Grieten L., Malbrain M., Tang W.H., Mullens W. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013; 62(6): 485–95. DOI: 10.1016/j.jacc.2013.04.070
31. House A.A., Anand I., Bellomo R., Cruz D., Bobek I., Anker S.D. et al. Acute Dialysis Quality Initiative Consensus Group. Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010; 25(5): 1416–20. DOI: 10.1093/ndt/gfq136
32. Campbell R.C., Sui X., Filippatos G., Love T.E., Wahle C., Sanders P.W. et al. Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol Dial Transplant. 2009; 24(1): 186–93. DOI: 10.1093/ndt/gfn445
33. Raina R., Nair N., Chakraborty R., Nemer L., Dasgupta R., Varian K. An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome. Cardiol Res. 2020; 11(2): 76–88. DOI: 10.14740/cr95
34. Hillege H.L., Nitsch D., Pfeffer M.A., Swedberg K., McMurray J.J., Yusuf S. et al. Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113(5): 671–8. DOI: 10.1161/CIRCULATIONAHA.105.580506
35. Ronco C., Bellasi A., Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018; 25(5): 382– 390. DOI: 10.1053/j.ackd.2018.08.004
36. Zarbock A., Küllmar M., Ostermann M., Lucchese G., Baig K., Cennamo A. et al. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg. 2021; 133(2): 292–302. DOI: 10.1213/ANE.0000000000005458
37. Angelini A., Castellani C., Virzì G.M., Fedrigo M., Thiene G., Valente M. et al. The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure. Cardiorenal Med. 2015; 6(1): 61–72. DOI: 10.1159/000440775
38. Hundae A., McCullough P.A. Cardiac and renal fibrosis in chronic cardiorenal syndromes. Nephron Clin Pract. 2014; 127(1–4): 106–12. DOI: 10.1159/000363705
39. Hao H., Ma S., Zheng C., Wang Q., Lin H., Chen Z. et al. Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome. Aging (Albany NY). 2021; 13(2): 2982–3009. DOI: 10.18632/aging.202448
40. Breidthardt T., Cox E.F., Squire I., Odudu A., Omar N.F., Eldehni M.T. et al. The pathophysiology of the chronic cardiorenal syndrome: a magnetic resonance imaging study. Eur Radiol. 2015; 25(6): 1684–91. DOI: 10.1007/s00330-014-3571-5
41. Iida N., Seo Y., Sai S., Machino-Ohtsuka T, Yamamoto M, Ishizu T et al. Clinical Implications of Intrarenal Hemodynamic Evaluation by Doppler Ultrasonography in Heart Failure. JACC Heart Fail. 2016; 4(8): 674–82. DOI: 10.1016/j.jchf.2016.03.016
42. Savira F., Magaye R., Liew D., Reid C., Kelly D.J., Kompa A.R. et al. Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature. Br J Pharmacol. 2020; 177(13): 2906–2922. DOI: 10.1111/bph.15065
43. Hanberg J.S., Sury K., Wilson F.P., Brisco M.A., Ahmad T., Ter Maaten J.M. et al. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. J Am Coll Cardiol. 2016; 67(19): 2199–2208. DOI: 10.1016/j.jacc.2016.02.058
44. Nohria A., Hasselblad V., Stebbins A., Pauly D.F., Fonarow G.C., Shah M. et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008; 51(13): 1268–1274. DOI: 10.1016/j.jacc.2007.08.072
45. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A. et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355(3): 260–9. DOI: 10.1056/NEJMoa051530
46. Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A. et al. Renal function, neurohor-monal activation, and survival in patients with chronic heart failure. Circulation. 2000; 102(2): 203–10. DOI: 10.1161/01.cir.102.2.203
47. Liang K.V., Williams A.W., Greene E.L., Redfield M.M. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med. 2008; 36(1): 75–88. DOI: 10.1097/01.CCM.0000296270.41256.5C
48. Wang J., Zhang W., Wu L., Mei Y., Cui S., Feng Z. et al. New insights into the pathophysiological mechanisms underlying cardiorenal syndrome. Aging (Albany NY). 2020; 12(12): 12422–12431. DOI: 10.18632/aging.103354
49. Arutyunov A.G., Bashkinov R.A., Batluk T.I., Melnikov E.S., Ermilova A.N. Acute kidney injury in patients with chronic heart failure. Yuzhno-Rossijskij zhurnal terapevticheskoj praktiki.2021; 2(3): 6–17 (in Russ.). DOI: 10.21886/2712-8156-2021-2-3-6-17
50. Makaritsis K.P., Liakopoulos V., Leivaditis K., Eleftheriadis T., Stefanidis I. Adaptation of renal function in heart failure. Ren Fail. 2006; 28(7): 527–35. DOI: 10.1080/08860220600839522
51. Bongartz L.G., Cramer M.J., Doevendans P.A., Joles J.A., Braam B. The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J. 2005; 26(1): 11–7. DOI: 10.1093/eurheartj/ehi020
52. Hostetter T.H., Ibrahim H.N. Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol. 2003; 14(9): 2395– 401. DOI: 10.1097/01.asn.0000086472.65806.73
53. Lin L., Zhou X., Dekkers I.A., Lamb H.J. Cardiorenal Syndrome: Emerging Role of Medical Imaging for Clinical Diagnosis and Management. J Pers Med. 2021; 11(8): 734. DOI: 10.3390/jpm11080734
54. McCullough P.A., Li S., Jurkovitz C.T., Stevens L.A., Wang C., Collins A.J. et al. Kidney Early Evaluation Program Investigators. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis. 2008; 51(4): 38–45. DOI: 10.1053/j.ajkd.2007.12.017
55. Leventoğlu E., Kavgacı A., Örün U.A., Büyükkaragöz B. Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome. Cardiorenal Med. 2025; 15: 358–373. DOI: 10.1159/000545791
56. Van den Eynde J., Rotbi H., Gewillig M., Kutty S., Allegaert K., Mekahli D. In-Hospital Outcomes of Acute Kidney Injury After Pediatric Cardiac Surgery: A Meta-Analysis. Front Pediatr. 2021;9:733744. DOI: 10.3389/fped.2021.733744
57. Sergeev S.A., Lomivorotov V.V. Acute kidney injury after cardiac surgery in children. Patologiya krovoobrashcheniya i kardiohirurgiya. 2021; 25(4): 11–22. (in Russ.). DOI: 10.21688/1681-3472-2021-4-11-22
58. Leventoğlu E., Kavgacı A., Örün Ua, Büyükkaragöz B. Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome. Cardiorenal Med. 2025; 15: 358–373. DOI: 10.1159/000545791
Review
For citations:
Pakhomov A.P., Zorin I.V. Current understanding of cardiorenal syndrome in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2026;71(2):18-24. (In Russ.) https://doi.org/10.21508/1027-4065-2026-71-2-18-24
Views:
269
JATS XML
Email this article 